Preskoči na vsebino

Travmatologija in urgentna medicina

Early Anemia Management

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (odpre novo okno)

Ball AM, Winstead PS.

Vir‎: Pharmacotherapy 2008;28(11):1383-90.

Indeksirano‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (odpre novo okno)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (odpre novo okno)

Charles A, Purtill M, Napolitano LM.

Vir‎: Anaesth Intensive Care 2006;34(6):793-6.

Indeksirano‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (odpre novo okno)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (odpre novo okno)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

Vir‎: N Engl J Med. 2023 2;389(18):1649-59.

Indeksirano‎: PubMed 37913505

DOI‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (odpre novo okno)

Bloodless management of the anemic patient in the emergency department. (odpre novo okno)

Johnson-Arbor K, Verstraete R

Vir‎: Ann Emerg Med 2022;79(1):48-57.

Indeksirano‎: PubMed 34353645

DOI‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (odpre novo okno)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (odpre novo okno)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Vir‎: J Trauma 2008;65(2):285-97.

Indeksirano‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (odpre novo okno)

Erythropoiesis in multiply injured patients. (odpre novo okno)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

Vir‎: J Trauma 2006;61(5):1285-91.

Indeksirano‎: PubMed 17099548

DOI‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (odpre novo okno)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (odpre novo okno)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Vir‎: Arch Surg 2012;147(3):251-5.

Indeksirano‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (odpre novo okno)